Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial

Similar Items

• Piperaquine pharmacokinetics during intermittent preventive treatment for malaria in pregnancy
  by: Chotsiri, P, et al.
  Published: (2021)
• Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
  by: Mwayiwawo Madanitsa, et al.
  Published: (2016-09-01)
• Impact of dolutegravir-based antiretroviral therapy on piperaquine exposure following dihydroartemisinin-piperaquine intermittent preventive treatment of malaria in pregnant women living with HIV
  by: Banda, CG, et al.
  Published: (2022)
• Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
  by: Badara Cisse, et al.
  Published: (2009-09-01)
• Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
  by: Roland Nnaemeka Okoro, et al.
  Published: (2023-01-01)